Capstone Investment Advisors »

Recursion Pharmaceuticals shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $143k 47k 3.07
2025-06-30 $204k 40k 5.06
2024-03-31 $161k 16k 9.97

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr China Lg-cap Etf (FXI)
Alphabet Cap Stk Cl A (GOOGL)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Meta Platforms Cl A (META)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Western Digital Corp Note 3.000%11/1 (Principal)

View all positions for Capstone Investment Advisors

Top funds holding Recursion Pharmaceuticals

BlackRock
ARK Investment Management
State Street Corporation
Baillie Gifford & Co
Vanguard Portfolio Management
Vanguard Capital Management
Softbank Group Corp
Geode Capital Management
MIC Capital Management UK
Susquehanna International
Goldman Sachs Group
Data Collective IV GP
Exor Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Recursion Pharmaceuticals